DAVITA INC.
DVAAPI behind this page
DVA Q1 2026 request
Playground key active
/api/financials?ticker=DVA&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts | 3,272,797 | 3,102,993 | +5.5% |
| Other Income | 142,751 | 120,536 | +18.4% |
Show Business Segments breakouts |
|||
| All Other Segments · Commercial Payors | 3,648 | 2,701 | +35.1% |
| All Other Segments · Medicare and Medicare Advantage | 108,506 | 98,954 | +9.7% |
| All Other Segments · Other | 27,610 | 15,599 | +77.0% |
| Other Operating Segments with Intersegment · Operating Segments | 136,476 | 114,528 | +19.2% |
| Other Operating Segments with Intersegment · Operating Segments | 3,288 | 2,728 | +20.5% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 6,275 | 6,008 | +4.4% |
| U. S. Dialysis And Related Lab Services · Other | 6,275 | 6,008 | +4.4% |
Show Health Care Organization Revenue Sources breakouts |
|||
| Commercial Payors | 3,648 | 2,701 | +35.1% |
| Medicare and Medicare Advantage | 108,506 | 98,954 | +9.7% |
| Other | 33,885 | 21,607 | +56.8% |
| Revenue | 3,415,548 | 3,223,529 | +6.0% |
Show Business Segments breakouts |
|||
| All Other Segments | 494,319 | 412,094 | +20.0% |
| All Other Segments · Intersegment Elimination | -3,288 | -2,728 | -20.5% |
| Other Operating Segments with Intersegment · Operating Segments | 497,607 | 414,822 | +20.0% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 2,941,701 | 2,823,169 | +4.2% |
| U. S. Dialysis And Related Lab Services | 2,921,229 | 2,811,435 | +3.9% |
| U. S. Dialysis And Related Lab Services · Intersegment Elimination | -20,472 | -11,734 | -74.5% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -23,760 | -14,462 | -64.3% |
| Operating Segments | 3,439,308 | 3,237,991 | +6.2% |
| Patient Care Costs | 2,342,257 | 2,239,660 | +4.6% |
Show Business Segments breakouts |
|||
| U. S. Dialysis And Related Lab Services · Operating Segments | 1,969,056 | 1,913,428 | +2.9% |
| General & Administrative | 421,914 | 374,090 | +12.8% |
Show Business Segments breakouts |
|||
| U. S. Dialysis And Related Lab Services · Operating Segments | 319,772 | 282,679 | +13.1% |
| Depreciation And Amortization | 177,829 | 176,451 | +0.8% |
Show Business Segments breakouts |
|||
| All Other Segments | 22,659 | 19,552 | +15.9% |
| U. S. Dialysis And Related Lab Services | 155,170 | 156,899 | -1.1% |
| Income Loss From Equity Method Investments | -8,344 | -5,609 | -48.8% |
| Total Costs & Expenses | 2,933,656 | 2,784,592 | +5.4% |
Show Business Segments breakouts |
|||
| U. S. Dialysis And Related Lab Services · Operating Segments | 2,435,734 | 2,347,397 | +3.8% |
| Operating Income | 481,892 | 438,937 | +9.8% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 5,832 | -2,809 | +307.6% |
| U. S. Dialysis And Related Lab Services · Operating Segments | 505,967 | 475,772 | +6.3% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 511,799 | 472,963 | +8.2% |
| Interest And Debt Expense | -145,131 | -135,055 | -7.5% |
| Other Non-Operating Income (Expense) | 4,473 | -17,549 | +125.5% |
| Income Before Taxes | 341,234 | 286,333 | +19.2% |
| Income Tax Expense (Benefit) | 66,199 | 54,117 | +22.3% |
| Net Income | 275,035 | 232,216 | +18.4% |
| Net Income Loss Attributable To Noncontrolling Interest | -77,505 | -69,299 | -11.8% |
| Net Income | 197,530 | 162,917 | +21.2% |
| EPS (Basic) | 2.93 | 2.05 | +42.9% |
| EPS (Diluted) | 2.87 | 2 | +43.5% |
| Wtd Avg Shares (Basic) | 67,390 | 79,368 | -15.1% |
| Wtd Avg Shares (Diluted) | 68,875 | 81,275 | -15.3% |
| Comprehensive Income | 233,354 | 246,745 | -5.4% |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax | 5,154 | -8,535 | +160.4% |
| Revenue From Contract With Customer Including Assessed Tax (Q) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Commercial Payors | 109,664 | 87,819 | +24.9% |
| All Other Segments · Other Government Payors | 248,179 | 209,747 | +18.3% |
| Other Operating Segments with Intersegment · Operating Segments | 357,843 | 297,566 | +20.3% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 2,935,426 | 2,817,161 | +4.2% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 2,914,954 | 2,805,427 | +3.9% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 20,472 | 11,734 | +74.5% |
| U. S. Dialysis And Related Lab Services · Commercial Payors | 954,243 | 924,888 | +3.2% |
| U. S. Dialysis And Related Lab Services · Medicaid and Managed Medicaid | 212,830 | 206,509 | +3.1% |
| U. S. Dialysis And Related Lab Services · Medicare and Medicare Advantage | 1,675,413 | 1,609,018 | +4.1% |
| U. S. Dialysis And Related Lab Services · Other Government Payors | 92,940 | 76,746 | +21.1% |
Show Health Care Organization Revenue Sources breakouts |
|||
| Commercial Payors | 1,063,907 | 1,012,707 | +5.1% |
| Medicaid and Managed Medicaid | 212,830 | 206,509 | +3.1% |
| Medicare and Medicare Advantage | 1,675,413 | 1,609,018 | +4.1% |
| Other Government Payors | 341,119 | 286,493 | +19.1% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 644,243 | 438,780 | +46.8% |
| Marketable Securities (Current) | 22,303 | 73,163 | -69.5% |
| Accounts Receivable | 2,459,355 | 2,321,818 | +5.9% |
| Inventory | 141,613 | 150,522 | -5.9% |
| Other Receivables Net Current | 517,653 | — | — |
Show Accounts Notes Loans And Financing Receivable By Receivable Type breakouts |
|||
| IKC and Medicare | 354,329 | — | — |
| Prepaid Expenses & Other Current Assets | 159,576 | 129,967 | +22.8% |
| Total Current Assets | 4,062,683 | 3,636,188 | +11.7% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 2,754,754 | 2,901,056 | -5.0% |
| Operating Lease Right-of-Use Assets | 2,396,698 | 2,360,829 | +1.5% |
| Marketable Securities (Non-Current) | 39,469 | 31,446 | +25.5% |
| Other Non-Current Assets | 266,987 | 238,933 | +11.7% |
| Goodwill | 7,582,313 | 7,415,560 | +2.2% |
Show Business Segments breakouts |
|||
| All Other Segments | 1,033,599 | 893,104 | +15.7% |
| U. S. Dialysis | 6,548,714 | — | — |
| Total Assets | 17,499,365 | 17,119,030 | +2.2% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 602,328 | 546,754 | +10.2% |
| Other Assets | |||
| Restricted Cash And Cash Equivalents | 82,160 | 85,793 | -4.2% |
| Income Taxes Receivable | 35,780 | 13,881 | +157.8% |
| Intangible Assets Net Excluding Goodwill | 229,020 | 205,263 | +11.6% |
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 167,441 | 329,755 | -49.2% |
| Current Liabilities | |||
| Accounts Payable | 691,256 | 596,137 | +16.0% |
| Other Liabilities Current | 799,377 | 900,188 | -11.2% |
| Employee Related Liabilities Current | 708,037 | 676,782 | +4.6% |
| Operating Lease Liability Current | 432,219 | 420,506 | +2.8% |
| Long Term Debt And Capital Lease Obligations Current | 112,653 | 178,648 | -36.9% |
| Accrued Income Taxes Current | 37,417 | 36,577 | +2.3% |
| Total Current Liabilities | 2,867,459 | 2,906,782 | -1.4% |
| Non-Current Liabilities | |||
| Operating Lease Liabilities | 2,162,372 | 2,161,439 | 0.0% |
| Other Non-Current Liabilities | 88,853 | 166,515 | -46.6% |
| Deferred Tax Liabilities | 818,918 | 664,580 | +23.2% |
| Total Liabilities | 16,451,199 | 15,459,061 | +6.4% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 228,092 | 252,238 | -9.6% |
| Other Liabilities | |||
| Due To Related Party | 86,500 | 97,944 | -11.7% |
Show Related Party Transaction breakouts |
|||
| Principal Owner | 86,500 | 97,944 | -11.7% |
| Long Term Debt And Capital Lease Obligations | 10,513,597 | 9,559,745 | +10.0% |
| Stockholders' Equity | |||
| Common Stock | 69 | 91 | -24.2% |
| Retained Earnings | -179,242 | 1,697,547 | -110.6% |
| Treasury Stock Value | -489,364 | -2,037,238 | +76.0% |
| Accumulated Other Comprehensive Income | -86,959 | -226,968 | +61.7% |
| Total Stockholders' Equity | -755,496 | -267,101 | -182.9% |
| Minority Interest | 279,157 | 260,549 | +7.1% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -476,339 | — | — |
Show Equity Components breakouts |
|||
| Accumulated Foreign Currency Adjustment Including Portion Attributable To Noncontrolling Interest | -72,592 | -211,429 | +65.7% |
| Accumulated Gain Loss Cash Flow Hedge Including Noncontrolling Interest | -14,367 | -15,585 | +7.8% |
| Accumulated Other Comprehensive Income | -86,959 | -226,968 | +61.7% |
| Aoci Including Portion Attributable To Noncontrolling Interest | -86,959 | -226,968 | +61.7% |
| Common Stock | 69 | 91 | -24.2% |
| Noncontrolling Interest | 279,157 | 260,549 | +7.1% |
| Parent | -755,496 | -267,101 | -182.9% |
| Retained Earnings | -179,242 | 1,697,547 | -110.6% |
| Treasury Stock Common | -489,364 | -2,037,238 | +76.0% |
| Total Liabilities & Equity | 17,499,365 | 17,119,030 | +2.2% |
| Redeemable Noncontrolling Interest Equity Carrying Amount | 1,524,505 | 1,666,521 | -8.5% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation Amortization And Accretion Net | 177,829 | 176,451 | +0.8% |
| Stock-Based Compensation | 28,160 | 29,759 | -5.4% |
| Deferred Income Taxes | 54,798 | 4,335 | +1164.1% |
| Adjustment Income Loss From Equity Method Investments | -30 | 20,262 | -100.1% |
| Other Non-Cash Items | 6,706 | 7,137 | -6.0% |
| Change in Accounts Receivable | -29,751 | -155,276 | +80.8% |
| Change in Inventory | 20,277 | -14,772 | +237.3% |
| Increase Decrease In Other Current Receivables And Other Current Assets | -22,772 | -41,087 | +44.6% |
| Increase Decrease In Other Noncurrent Assets | -2,571 | 13,026 | -119.7% |
| Change in Accounts Payable | -23,774 | 46,195 | -151.5% |
| Increase Decrease In Employee Related Liabilities | -88,343 | -128,194 | +31.1% |
| Increase Decrease In Other Current Liabilities | -96,903 | -39,394 | -146.0% |
| Increase Decrease In Accrued Income Taxes Payable | 27,125 | 39,829 | -31.9% |
| Change in Other Liabilities | -4,955 | -10,478 | +52.7% |
| Net Cash from Operations | 320,831 | 180,009 | +78.2% |
| Investing Activities | |||
| Capital Expenditures | -102,018 | -143,258 | +28.8% |
| Payments To Acquire Businesses Gross | -33,924 | -10,243 | -231.2% |
| Proceeds From Sales Of Business Affiliate And Productive Assets | 3,721 | 10,674 | -65.1% |
| Payments To Acquire Held To Maturity Securities | -290 | -26,894 | +98.9% |
| Payments To Acquire Other Investments | -9,655 | -2,471 | -290.7% |
| Proceeds From Sale And Maturity Of Held To Maturity Securities | 942 | 3,080 | -69.4% |
| Proceeds From Sale And Maturity Of Other Investments | 4,332 | 5,662 | -23.5% |
| Payments To Acquire Equity Method Investments | -2,308 | — | — |
| Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital | 109 | 1,312 | -91.7% |
| Net Cash from Investing | -139,091 | -162,138 | +14.2% |
| Financing Activities | |||
| Proceeds From Issuance Of Long Term Debt | 1,263,179 | 633,189 | +99.5% |
| Repayments Of Debt And Capital Lease Obligations | -917,087 | -345,965 | -165.1% |
| Payments Of Financing Costs | -2,882 | -6,411 | +55.0% |
| Purchase Of Treasury Stock From Related Party | -199,940 | -31,684 | -531.0% |
| Share Repurchases | -196,371 | -510,161 | +61.5% |
| Payments Of Distributions To Affiliates | -85,440 | -93,022 | +8.2% |
| Net Proceeds From Issuance Of Stock To Employees | 2,386 | 4,937 | -51.7% |
| Tax Withholding for Share Compensation | -63,155 | -30,214 | -109.0% |
| Proceeds From Contributions From Affiliates | 4,049 | 2,169 | +86.7% |
| Payments To Minority Shareholders | -18,082 | -5,378 | -236.2% |
| Net Cash from Financing | -213,343 | -382,540 | +44.2% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 259 | 9,417 | -97.2% |
| Net Change in Cash | -31,344 | -355,252 | +91.2% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 726,403 | 524,573 | +38.5% |
Values in thousands USD. Source: SEC EDGAR 10-Q filing.